देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
Saccharomyces cerevisiae (Boulardii), Quantity: 5 billion CFU; Lactobacillus gasseri, Quantity: 2 billion CFU; Lactobacillus reuteri, Quantity: 3 billion CFU; Bifidobacterium breve, Quantity: 5 billion CFU; Lactobacillus rhamnosus, Quantity: 5 billion CFU
Spectrumceuticals Pty Ltd
Bifidobacterium breve,Lactobacillus gasseri,Lactobacillus reuteri,Lactobacillus rhamnosus,Saccharomyces cerevisiae (Boulardii)
Capsule, hard
Excipient Ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; hypromellose; purified water
Oral
Maintain/support general health and wellbeing ; Maintain/support intestinal health ; Maintain/support intestinal good/beneficial/friendly flora ; Maintain/support small intestine good/beneficial/friendly flora ; Maintain/support gastrointestinal system health ; Maintain/support gastrointestinal mucosal membrane health ; Maintain/support immune system health ; Maintain/support healthy immune system function ; Maintain/support healthy gastrointestinal immune function
Visual Identification: ;
Licence status A
2017-09-13